<DOC>
	<DOC>NCT00033085</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.</brief_summary>
	<brief_title>Ondansetron for the Treatment of Cocaine Dependence - 1</brief_title>
	<detailed_description>Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male/Female, at least 18 yrs of age; DSM4 diagnosis of cocaine dependence; seeking Treatment for cocaine dependence; have ability to understand, having understood and provide written consent; females of child bearing potential that use accepted method of birth control Additional criteria available during screening at the site.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>